- Home
- AAMI vs QDEL Comparison
AAMI vs QDEL Comparison
Compare AAMI & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AAMI | QDEL |
|---|---|---|
| Founded | 1980 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.7B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | AAMI | QDEL |
|---|---|---|
| Price | $55.61 | $30.50 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 3 | 6 |
| Target Price | ★ $48.67 | $40.00 |
| AVG Volume (30 Days) | 186.2K | ★ 880.8K |
| Earning Date | 02-05-2026 | 02-11-2026 |
| Dividend Yield | ★ 0.07% | N/A |
| EPS Growth | ★ 45.00 | N/A |
| EPS | ★ 2.40 | N/A |
| Revenue | $559,300,000.00 | ★ $2,714,400,000.00 |
| Revenue This Year | $17.23 | N/A |
| Revenue Next Year | $24.02 | $2.42 |
| P/E Ratio | $22.91 | ★ N/A |
| Revenue Growth | ★ 19.25 | N/A |
| 52 Week Low | $22.60 | $19.50 |
| 52 Week High | $55.38 | $46.24 |
Technical Indicators
Market Signals| Indicator | AAMI | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 75.56 | 48.99 |
| Support Level | $52.00 | $27.19 |
| Resistance Level | $55.10 | $35.58 |
| Average True Range (ATR) | 1.99 | 2.10 |
| MACD | 0.44 | -0.37 |
| Stochastic Oscillator | 92.66 | 41.20 |
Price Performance
Historical ComparisonAbout AAMI Acadian Asset Management Inc.
Acadian Asset Management Inc is a holding company that operates a systematic investment management business through its subsidiary, that offers institutional investors across the globe access to a diversified array of systematic investment strategies designed to meet a range of risk and return objectives.
About QDEL QuidelOrtho Corporation
QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America.